nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—CYP3A4—Temozolomide—brain cancer	0.193	0.486	CbGbCtD
Paricalcitol—CYP3A4—Lomustine—brain cancer	0.164	0.414	CbGbCtD
Paricalcitol—CYP3A4—Etoposide—brain cancer	0.0396	0.0999	CbGbCtD
Paricalcitol—UGT1A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.0114	0.0945	CbGpPWpGaD
Paricalcitol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00966	0.0804	CbGpPWpGaD
Paricalcitol—UGT1A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00811	0.0675	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00809	0.0674	CbGpPWpGaD
Paricalcitol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00613	0.0511	CbGpPWpGaD
Paricalcitol—CYP24A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00605	0.0504	CbGpPWpGaD
Paricalcitol—CYP24A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00497	0.0414	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—HIC1—brain cancer	0.00454	0.0378	CbGpPWpGaD
Paricalcitol—VDR—Ovarian Infertility Genes—ESR2—brain cancer	0.00393	0.0327	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors—ESR2—brain cancer	0.00342	0.0285	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of TAp63 isoforms—SHH—brain cancer	0.00323	0.0269	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00271	0.0225	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—CYP2C9—brain cancer	0.00264	0.022	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—CYP2C9—brain cancer	0.0026	0.0217	CbGpPWpGaD
Paricalcitol—VDR—Ovarian Infertility Genes—CDK4—brain cancer	0.00239	0.0199	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—PMS2—brain cancer	0.00239	0.0199	CbGpPWpGaD
Paricalcitol—Cholecalciferol—CYP2C9—brain cancer	0.00237	1	CrCbGaD
Paricalcitol—VDR—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—brain cancer	0.00237	0.0198	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of deltaNp63 isoforms—HES1—brain cancer	0.00224	0.0187	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.00218	0.0181	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—CYP2C9—brain cancer	0.00211	0.0176	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—CYP2C9—brain cancer	0.00208	0.0173	CbGpPWpGaD
Paricalcitol—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.00192	0.016	CbGpPWpGaD
Paricalcitol—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00184	0.0153	CbGpPWpGaD
Paricalcitol—Dysphagia—Temozolomide—brain cancer	0.00151	0.00314	CcSEcCtD
Paricalcitol—Hypertension—Procarbazine—brain cancer	0.0015	0.00312	CcSEcCtD
Paricalcitol—Myalgia—Procarbazine—brain cancer	0.00148	0.00308	CcSEcCtD
Paricalcitol—Arthralgia—Procarbazine—brain cancer	0.00148	0.00308	CcSEcCtD
Paricalcitol—Anxiety—Procarbazine—brain cancer	0.00148	0.00307	CcSEcCtD
Paricalcitol—Dry mouth—Procarbazine—brain cancer	0.00145	0.00301	CcSEcCtD
Paricalcitol—Confusional state—Procarbazine—brain cancer	0.00143	0.00298	CcSEcCtD
Paricalcitol—Vomiting—Lomustine—brain cancer	0.00142	0.00296	CcSEcCtD
Paricalcitol—Oedema—Procarbazine—brain cancer	0.00142	0.00295	CcSEcCtD
Paricalcitol—Infection—Procarbazine—brain cancer	0.00141	0.00293	CcSEcCtD
Paricalcitol—Angiopathy—Hydroxyurea—brain cancer	0.0014	0.00292	CcSEcCtD
Paricalcitol—Upper respiratory tract infection—Temozolomide—brain cancer	0.0014	0.00292	CcSEcCtD
Paricalcitol—Pneumonia—Carmustine—brain cancer	0.0014	0.00291	CcSEcCtD
Paricalcitol—Shock—Procarbazine—brain cancer	0.0014	0.0029	CcSEcCtD
Paricalcitol—Erectile dysfunction—Temozolomide—brain cancer	0.00139	0.00289	CcSEcCtD
Paricalcitol—Depression—Carmustine—brain cancer	0.00139	0.00289	CcSEcCtD
Paricalcitol—Chills—Hydroxyurea—brain cancer	0.00139	0.00289	CcSEcCtD
Paricalcitol—Hyperhidrosis—Procarbazine—brain cancer	0.00137	0.00285	CcSEcCtD
Paricalcitol—Alopecia—Hydroxyurea—brain cancer	0.00137	0.00284	CcSEcCtD
Paricalcitol—Weight decreased—Temozolomide—brain cancer	0.00137	0.00284	CcSEcCtD
Paricalcitol—Urinary tract infection—Carmustine—brain cancer	0.00136	0.00281	CcSEcCtD
Paricalcitol—Pneumonia—Temozolomide—brain cancer	0.00136	0.00281	CcSEcCtD
Paricalcitol—Anorexia—Procarbazine—brain cancer	0.00135	0.00281	CcSEcCtD
Paricalcitol—Infestation NOS—Temozolomide—brain cancer	0.00135	0.0028	CcSEcCtD
Paricalcitol—Infestation—Temozolomide—brain cancer	0.00135	0.0028	CcSEcCtD
Paricalcitol—VDR—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—brain cancer	0.00135	0.0112	CbGpPWpGaD
Paricalcitol—Depression—Temozolomide—brain cancer	0.00134	0.00279	CcSEcCtD
Paricalcitol—Cardiac arrest—Etoposide—brain cancer	0.00133	0.00276	CcSEcCtD
Paricalcitol—Nausea—Lomustine—brain cancer	0.00133	0.00276	CcSEcCtD
Paricalcitol—Hypotension—Procarbazine—brain cancer	0.00133	0.00276	CcSEcCtD
Paricalcitol—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00132	0.011	CbGpPWpGaD
Paricalcitol—Urinary tract infection—Temozolomide—brain cancer	0.00131	0.00272	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00129	0.00269	CcSEcCtD
Paricalcitol—Insomnia—Procarbazine—brain cancer	0.00129	0.00267	CcSEcCtD
Paricalcitol—Paraesthesia—Procarbazine—brain cancer	0.00128	0.00265	CcSEcCtD
Paricalcitol—Sinusitis—Temozolomide—brain cancer	0.00126	0.00263	CcSEcCtD
Paricalcitol—Somnolence—Procarbazine—brain cancer	0.00126	0.00262	CcSEcCtD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00125	0.0104	CbGpPWpGaD
Paricalcitol—Ill-defined disorder—Hydroxyurea—brain cancer	0.00125	0.0026	CcSEcCtD
Paricalcitol—Anaemia—Hydroxyurea—brain cancer	0.00125	0.00259	CcSEcCtD
Paricalcitol—Hypoaesthesia—Carmustine—brain cancer	0.00125	0.00259	CcSEcCtD
Paricalcitol—Decreased appetite—Procarbazine—brain cancer	0.00124	0.00257	CcSEcCtD
Paricalcitol—Oedema peripheral—Carmustine—brain cancer	0.00123	0.00256	CcSEcCtD
Paricalcitol—Connective tissue disorder—Carmustine—brain cancer	0.00123	0.00255	CcSEcCtD
Paricalcitol—Fatigue—Procarbazine—brain cancer	0.00123	0.00255	CcSEcCtD
Paricalcitol—Malaise—Hydroxyurea—brain cancer	0.00122	0.00252	CcSEcCtD
Paricalcitol—Constipation—Procarbazine—brain cancer	0.00122	0.00252	CcSEcCtD
Paricalcitol—Pain—Procarbazine—brain cancer	0.00122	0.00252	CcSEcCtD
Paricalcitol—Dysphagia—Etoposide—brain cancer	0.00121	0.00251	CcSEcCtD
Paricalcitol—Leukopenia—Hydroxyurea—brain cancer	0.00121	0.00251	CcSEcCtD
Paricalcitol—VDR—Validated transcriptional targets of TAp63 isoforms—CDKN2A—brain cancer	0.0012	0.01	CbGpPWpGaD
Paricalcitol—Hypoaesthesia—Temozolomide—brain cancer	0.0012	0.0025	CcSEcCtD
Paricalcitol—Pharyngitis—Temozolomide—brain cancer	0.0012	0.00249	CcSEcCtD
Paricalcitol—Urinary tract disorder—Temozolomide—brain cancer	0.00119	0.00248	CcSEcCtD
Paricalcitol—Oedema peripheral—Temozolomide—brain cancer	0.00119	0.00247	CcSEcCtD
Paricalcitol—Connective tissue disorder—Temozolomide—brain cancer	0.00119	0.00247	CcSEcCtD
Paricalcitol—Urethral disorder—Temozolomide—brain cancer	0.00119	0.00246	CcSEcCtD
Paricalcitol—Feeling abnormal—Procarbazine—brain cancer	0.00117	0.00243	CcSEcCtD
Paricalcitol—Eye disorder—Carmustine—brain cancer	0.00117	0.00243	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Procarbazine—brain cancer	0.00116	0.00241	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00114	0.00237	CcSEcCtD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.00114	0.00948	CbGpPWpGaD
Paricalcitol—Discomfort—Hydroxyurea—brain cancer	0.00113	0.00235	CcSEcCtD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.00113	0.00942	CbGpPWpGaD
Paricalcitol—Eye disorder—Temozolomide—brain cancer	0.00113	0.00235	CcSEcCtD
Paricalcitol—Urticaria—Procarbazine—brain cancer	0.00113	0.00235	CcSEcCtD
Paricalcitol—Abdominal pain—Procarbazine—brain cancer	0.00112	0.00233	CcSEcCtD
Paricalcitol—Body temperature increased—Procarbazine—brain cancer	0.00112	0.00233	CcSEcCtD
Paricalcitol—Cardiac disorder—Temozolomide—brain cancer	0.00112	0.00233	CcSEcCtD
Paricalcitol—Arrhythmia—Carmustine—brain cancer	0.00112	0.00232	CcSEcCtD
Paricalcitol—Alopecia—Carmustine—brain cancer	0.00111	0.0023	CcSEcCtD
Paricalcitol—Oedema—Hydroxyurea—brain cancer	0.0011	0.00228	CcSEcCtD
Paricalcitol—Angiopathy—Temozolomide—brain cancer	0.0011	0.00228	CcSEcCtD
Paricalcitol—Mental disorder—Carmustine—brain cancer	0.0011	0.00228	CcSEcCtD
Paricalcitol—Infection—Hydroxyurea—brain cancer	0.00109	0.00227	CcSEcCtD
Paricalcitol—Immune system disorder—Temozolomide—brain cancer	0.00109	0.00227	CcSEcCtD
Paricalcitol—Mediastinal disorder—Temozolomide—brain cancer	0.00109	0.00226	CcSEcCtD
Paricalcitol—Malnutrition—Carmustine—brain cancer	0.00109	0.00226	CcSEcCtD
Paricalcitol—Chills—Temozolomide—brain cancer	0.00109	0.00225	CcSEcCtD
Paricalcitol—Pneumonia—Etoposide—brain cancer	0.00108	0.00225	CcSEcCtD
Paricalcitol—Nervous system disorder—Hydroxyurea—brain cancer	0.00108	0.00224	CcSEcCtD
Paricalcitol—Infestation NOS—Etoposide—brain cancer	0.00108	0.00224	CcSEcCtD
Paricalcitol—Infestation—Etoposide—brain cancer	0.00108	0.00224	CcSEcCtD
Paricalcitol—Alopecia—Temozolomide—brain cancer	0.00107	0.00222	CcSEcCtD
Paricalcitol—Skin disorder—Hydroxyurea—brain cancer	0.00107	0.00222	CcSEcCtD
Paricalcitol—Mental disorder—Temozolomide—brain cancer	0.00106	0.0022	CcSEcCtD
Paricalcitol—Back pain—Carmustine—brain cancer	0.00105	0.00219	CcSEcCtD
Paricalcitol—Malnutrition—Temozolomide—brain cancer	0.00105	0.00219	CcSEcCtD
Paricalcitol—Anorexia—Hydroxyurea—brain cancer	0.00105	0.00218	CcSEcCtD
Paricalcitol—Hypersensitivity—Procarbazine—brain cancer	0.00105	0.00217	CcSEcCtD
Paricalcitol—Dysgeusia—Temozolomide—brain cancer	0.00103	0.00214	CcSEcCtD
Paricalcitol—Asthenia—Procarbazine—brain cancer	0.00102	0.00212	CcSEcCtD
Paricalcitol—Back pain—Temozolomide—brain cancer	0.00102	0.00212	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00101	0.00844	CbGpPWpGaD
Paricalcitol—Anaemia—Carmustine—brain cancer	0.00101	0.00209	CcSEcCtD
Paricalcitol—Pruritus—Procarbazine—brain cancer	0.00101	0.00209	CcSEcCtD
Paricalcitol—Agitation—Carmustine—brain cancer	0.001	0.00208	CcSEcCtD
Paricalcitol—Dyspnoea—Hydroxyurea—brain cancer	0.000981	0.00204	CcSEcCtD
Paricalcitol—Somnolence—Hydroxyurea—brain cancer	0.000978	0.00203	CcSEcCtD
Paricalcitol—Ill-defined disorder—Temozolomide—brain cancer	0.000977	0.00203	CcSEcCtD
Paricalcitol—Leukopenia—Carmustine—brain cancer	0.000975	0.00203	CcSEcCtD
Paricalcitol—Anaemia—Temozolomide—brain cancer	0.000973	0.00202	CcSEcCtD
Paricalcitol—Diarrhoea—Procarbazine—brain cancer	0.000973	0.00202	CcSEcCtD
Paricalcitol—Dyspepsia—Hydroxyurea—brain cancer	0.000968	0.00201	CcSEcCtD
Paricalcitol—Agitation—Temozolomide—brain cancer	0.000968	0.00201	CcSEcCtD
Paricalcitol—Hypoaesthesia—Etoposide—brain cancer	0.000963	0.002	CcSEcCtD
Paricalcitol—Angioedema—Temozolomide—brain cancer	0.000962	0.002	CcSEcCtD
Paricalcitol—Decreased appetite—Hydroxyurea—brain cancer	0.000956	0.00199	CcSEcCtD
Paricalcitol—Urinary tract disorder—Etoposide—brain cancer	0.000956	0.00199	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00095	0.00197	CcSEcCtD
Paricalcitol—Malaise—Temozolomide—brain cancer	0.00095	0.00197	CcSEcCtD
Paricalcitol—Urethral disorder—Etoposide—brain cancer	0.000949	0.00197	CcSEcCtD
Paricalcitol—Fatigue—Hydroxyurea—brain cancer	0.000948	0.00197	CcSEcCtD
Paricalcitol—Vertigo—Temozolomide—brain cancer	0.000946	0.00196	CcSEcCtD
Paricalcitol—Leukopenia—Temozolomide—brain cancer	0.000943	0.00196	CcSEcCtD
Paricalcitol—Hypertension—Carmustine—brain cancer	0.000941	0.00195	CcSEcCtD
Paricalcitol—Constipation—Hydroxyurea—brain cancer	0.000941	0.00195	CcSEcCtD
Paricalcitol—Pain—Hydroxyurea—brain cancer	0.000941	0.00195	CcSEcCtD
Paricalcitol—Dizziness—Procarbazine—brain cancer	0.00094	0.00195	CcSEcCtD
Paricalcitol—Palpitations—Temozolomide—brain cancer	0.000931	0.00193	CcSEcCtD
Paricalcitol—Myalgia—Carmustine—brain cancer	0.000928	0.00193	CcSEcCtD
Paricalcitol—Chest pain—Carmustine—brain cancer	0.000928	0.00193	CcSEcCtD
Paricalcitol—Anxiety—Carmustine—brain cancer	0.000924	0.00192	CcSEcCtD
Paricalcitol—Cough—Temozolomide—brain cancer	0.000919	0.00191	CcSEcCtD
Paricalcitol—Hypertension—Temozolomide—brain cancer	0.000909	0.00189	CcSEcCtD
Paricalcitol—Feeling abnormal—Hydroxyurea—brain cancer	0.000906	0.00188	CcSEcCtD
Paricalcitol—Eye disorder—Etoposide—brain cancer	0.000905	0.00188	CcSEcCtD
Paricalcitol—Vomiting—Procarbazine—brain cancer	0.000904	0.00188	CcSEcCtD
Paricalcitol—Cardiac disorder—Etoposide—brain cancer	0.000898	0.00187	CcSEcCtD
Paricalcitol—Confusional state—Carmustine—brain cancer	0.000897	0.00186	CcSEcCtD
Paricalcitol—Arthralgia—Temozolomide—brain cancer	0.000896	0.00186	CcSEcCtD
Paricalcitol—Myalgia—Temozolomide—brain cancer	0.000896	0.00186	CcSEcCtD
Paricalcitol—Rash—Procarbazine—brain cancer	0.000896	0.00186	CcSEcCtD
Paricalcitol—Dermatitis—Procarbazine—brain cancer	0.000895	0.00186	CcSEcCtD
Paricalcitol—Anxiety—Temozolomide—brain cancer	0.000893	0.00186	CcSEcCtD
Paricalcitol—Headache—Procarbazine—brain cancer	0.00089	0.00185	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00089	0.00185	CcSEcCtD
Paricalcitol—Oedema—Carmustine—brain cancer	0.000889	0.00185	CcSEcCtD
Paricalcitol—Discomfort—Temozolomide—brain cancer	0.000886	0.00184	CcSEcCtD
Paricalcitol—Infection—Carmustine—brain cancer	0.000883	0.00183	CcSEcCtD
Paricalcitol—Angiopathy—Etoposide—brain cancer	0.000878	0.00182	CcSEcCtD
Paricalcitol—Dry mouth—Temozolomide—brain cancer	0.000877	0.00182	CcSEcCtD
Paricalcitol—Immune system disorder—Etoposide—brain cancer	0.000874	0.00182	CcSEcCtD
Paricalcitol—Mediastinal disorder—Etoposide—brain cancer	0.000872	0.00181	CcSEcCtD
Paricalcitol—Body temperature increased—Hydroxyurea—brain cancer	0.00087	0.00181	CcSEcCtD
Paricalcitol—Chills—Etoposide—brain cancer	0.000868	0.0018	CcSEcCtD
Paricalcitol—Confusional state—Temozolomide—brain cancer	0.000867	0.0018	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—SPP1—brain cancer	0.000866	0.00721	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000865	0.0072	CbGpPWpGaD
Paricalcitol—Oedema—Temozolomide—brain cancer	0.000859	0.00178	CcSEcCtD
Paricalcitol—Alopecia—Etoposide—brain cancer	0.000855	0.00178	CcSEcCtD
Paricalcitol—Infection—Temozolomide—brain cancer	0.000854	0.00177	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—PCNA—brain cancer	0.00085	0.00708	CbGpPWpGaD
Paricalcitol—Anorexia—Carmustine—brain cancer	0.000848	0.00176	CcSEcCtD
Paricalcitol—Nausea—Procarbazine—brain cancer	0.000844	0.00175	CcSEcCtD
Paricalcitol—Nervous system disorder—Temozolomide—brain cancer	0.000843	0.00175	CcSEcCtD
Paricalcitol—Skin disorder—Temozolomide—brain cancer	0.000835	0.00173	CcSEcCtD
Paricalcitol—Hypotension—Carmustine—brain cancer	0.000831	0.00173	CcSEcCtD
Paricalcitol—Hyperhidrosis—Temozolomide—brain cancer	0.000831	0.00173	CcSEcCtD
Paricalcitol—Dysgeusia—Etoposide—brain cancer	0.000825	0.00171	CcSEcCtD
Paricalcitol—Anorexia—Temozolomide—brain cancer	0.000819	0.0017	CcSEcCtD
Paricalcitol—Back pain—Etoposide—brain cancer	0.000815	0.00169	CcSEcCtD
Paricalcitol—Hypersensitivity—Hydroxyurea—brain cancer	0.00081	0.00168	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Carmustine—brain cancer	0.00081	0.00168	CcSEcCtD
Paricalcitol—Muscle spasms—Etoposide—brain cancer	0.00081	0.00168	CcSEcCtD
Paricalcitol—Insomnia—Carmustine—brain cancer	0.000804	0.00167	CcSEcCtD
Paricalcitol—Paraesthesia—Carmustine—brain cancer	0.000799	0.00166	CcSEcCtD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000796	0.00663	CbGpPWpGaD
Paricalcitol—Dyspnoea—Carmustine—brain cancer	0.000793	0.00165	CcSEcCtD
Paricalcitol—Somnolence—Carmustine—brain cancer	0.000791	0.00164	CcSEcCtD
Paricalcitol—Asthenia—Hydroxyurea—brain cancer	0.000789	0.00164	CcSEcCtD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000785	0.00654	CbGpPWpGaD
Paricalcitol—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000783	0.00163	CcSEcCtD
Paricalcitol—Ill-defined disorder—Etoposide—brain cancer	0.000782	0.00162	CcSEcCtD
Paricalcitol—Anaemia—Etoposide—brain cancer	0.000779	0.00162	CcSEcCtD
Paricalcitol—Insomnia—Temozolomide—brain cancer	0.000777	0.00161	CcSEcCtD
Paricalcitol—Decreased appetite—Carmustine—brain cancer	0.000773	0.00161	CcSEcCtD
Paricalcitol—Paraesthesia—Temozolomide—brain cancer	0.000772	0.0016	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Carmustine—brain cancer	0.000768	0.00159	CcSEcCtD
Paricalcitol—Dyspnoea—Temozolomide—brain cancer	0.000766	0.00159	CcSEcCtD
Paricalcitol—Somnolence—Temozolomide—brain cancer	0.000764	0.00159	CcSEcCtD
Paricalcitol—Constipation—Carmustine—brain cancer	0.00076	0.00158	CcSEcCtD
Paricalcitol—Pain—Carmustine—brain cancer	0.00076	0.00158	CcSEcCtD
Paricalcitol—Malaise—Etoposide—brain cancer	0.00076	0.00158	CcSEcCtD
Paricalcitol—Vertigo—Etoposide—brain cancer	0.000757	0.00157	CcSEcCtD
Paricalcitol—Dyspepsia—Temozolomide—brain cancer	0.000756	0.00157	CcSEcCtD
Paricalcitol—Leukopenia—Etoposide—brain cancer	0.000754	0.00157	CcSEcCtD
Paricalcitol—Diarrhoea—Hydroxyurea—brain cancer	0.000753	0.00156	CcSEcCtD
Paricalcitol—Decreased appetite—Temozolomide—brain cancer	0.000747	0.00155	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Temozolomide—brain cancer	0.000742	0.00154	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000741	0.00617	CbGpPWpGaD
Paricalcitol—Fatigue—Temozolomide—brain cancer	0.000741	0.00154	CcSEcCtD
Paricalcitol—Loss of consciousness—Etoposide—brain cancer	0.000741	0.00154	CcSEcCtD
Paricalcitol—Cough—Etoposide—brain cancer	0.000735	0.00153	CcSEcCtD
Paricalcitol—Pain—Temozolomide—brain cancer	0.000735	0.00153	CcSEcCtD
Paricalcitol—Constipation—Temozolomide—brain cancer	0.000735	0.00153	CcSEcCtD
Paricalcitol—Feeling abnormal—Carmustine—brain cancer	0.000733	0.00152	CcSEcCtD
Paricalcitol—Hypertension—Etoposide—brain cancer	0.000727	0.00151	CcSEcCtD
Paricalcitol—Dizziness—Hydroxyurea—brain cancer	0.000727	0.00151	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Carmustine—brain cancer	0.000727	0.00151	CcSEcCtD
Paricalcitol—Chest pain—Etoposide—brain cancer	0.000717	0.00149	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000712	0.00148	CcSEcCtD
Paricalcitol—Discomfort—Etoposide—brain cancer	0.000709	0.00147	CcSEcCtD
Paricalcitol—Feeling abnormal—Temozolomide—brain cancer	0.000708	0.00147	CcSEcCtD
Paricalcitol—Abdominal pain—Carmustine—brain cancer	0.000703	0.00146	CcSEcCtD
Paricalcitol—Body temperature increased—Carmustine—brain cancer	0.000703	0.00146	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Temozolomide—brain cancer	0.000703	0.00146	CcSEcCtD
Paricalcitol—Vomiting—Hydroxyurea—brain cancer	0.000699	0.00145	CcSEcCtD
Paricalcitol—Rash—Hydroxyurea—brain cancer	0.000694	0.00144	CcSEcCtD
Paricalcitol—Confusional state—Etoposide—brain cancer	0.000693	0.00144	CcSEcCtD
Paricalcitol—Dermatitis—Hydroxyurea—brain cancer	0.000693	0.00144	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—APC—brain cancer	0.000692	0.00576	CbGpPWpGaD
Paricalcitol—Headache—Hydroxyurea—brain cancer	0.000689	0.00143	CcSEcCtD
Paricalcitol—Infection—Etoposide—brain cancer	0.000683	0.00142	CcSEcCtD
Paricalcitol—Urticaria—Temozolomide—brain cancer	0.000683	0.00142	CcSEcCtD
Paricalcitol—Abdominal pain—Temozolomide—brain cancer	0.000679	0.00141	CcSEcCtD
Paricalcitol—Body temperature increased—Temozolomide—brain cancer	0.000679	0.00141	CcSEcCtD
Paricalcitol—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000676	0.00563	CbGpPWpGaD
Paricalcitol—Skin disorder—Etoposide—brain cancer	0.000668	0.00139	CcSEcCtD
Paricalcitol—Hyperhidrosis—Etoposide—brain cancer	0.000665	0.00138	CcSEcCtD
Paricalcitol—Anorexia—Etoposide—brain cancer	0.000655	0.00136	CcSEcCtD
Paricalcitol—Hypersensitivity—Carmustine—brain cancer	0.000655	0.00136	CcSEcCtD
Paricalcitol—Nausea—Hydroxyurea—brain cancer	0.000653	0.00136	CcSEcCtD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000645	0.00537	CbGpPWpGaD
Paricalcitol—Hypotension—Etoposide—brain cancer	0.000643	0.00133	CcSEcCtD
Paricalcitol—Asthenia—Carmustine—brain cancer	0.000638	0.00133	CcSEcCtD
Paricalcitol—Hypersensitivity—Temozolomide—brain cancer	0.000633	0.00131	CcSEcCtD
Paricalcitol—Paraesthesia—Etoposide—brain cancer	0.000617	0.00128	CcSEcCtD
Paricalcitol—Asthenia—Temozolomide—brain cancer	0.000617	0.00128	CcSEcCtD
Paricalcitol—Dyspnoea—Etoposide—brain cancer	0.000613	0.00127	CcSEcCtD
Paricalcitol—Somnolence—Etoposide—brain cancer	0.000611	0.00127	CcSEcCtD
Paricalcitol—Diarrhoea—Carmustine—brain cancer	0.000608	0.00126	CcSEcCtD
Paricalcitol—Pruritus—Temozolomide—brain cancer	0.000608	0.00126	CcSEcCtD
Paricalcitol—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000599	0.00499	CbGpPWpGaD
Paricalcitol—Decreased appetite—Etoposide—brain cancer	0.000598	0.00124	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Etoposide—brain cancer	0.000594	0.00123	CcSEcCtD
Paricalcitol—Fatigue—Etoposide—brain cancer	0.000593	0.00123	CcSEcCtD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.00059	0.00491	CbGpPWpGaD
Paricalcitol—Dizziness—Carmustine—brain cancer	0.000588	0.00122	CcSEcCtD
Paricalcitol—Constipation—Etoposide—brain cancer	0.000588	0.00122	CcSEcCtD
Paricalcitol—Pain—Etoposide—brain cancer	0.000588	0.00122	CcSEcCtD
Paricalcitol—Diarrhoea—Temozolomide—brain cancer	0.000588	0.00122	CcSEcCtD
Paricalcitol—Dizziness—Temozolomide—brain cancer	0.000568	0.00118	CcSEcCtD
Paricalcitol—Feeling abnormal—Etoposide—brain cancer	0.000567	0.00118	CcSEcCtD
Paricalcitol—Vomiting—Carmustine—brain cancer	0.000565	0.00117	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Etoposide—brain cancer	0.000562	0.00117	CcSEcCtD
Paricalcitol—Rash—Carmustine—brain cancer	0.000561	0.00116	CcSEcCtD
Paricalcitol—Dermatitis—Carmustine—brain cancer	0.00056	0.00116	CcSEcCtD
Paricalcitol—Headache—Carmustine—brain cancer	0.000557	0.00116	CcSEcCtD
Paricalcitol—Vomiting—Temozolomide—brain cancer	0.000546	0.00113	CcSEcCtD
Paricalcitol—Urticaria—Etoposide—brain cancer	0.000546	0.00113	CcSEcCtD
Paricalcitol—Abdominal pain—Etoposide—brain cancer	0.000544	0.00113	CcSEcCtD
Paricalcitol—Body temperature increased—Etoposide—brain cancer	0.000544	0.00113	CcSEcCtD
Paricalcitol—Rash—Temozolomide—brain cancer	0.000542	0.00113	CcSEcCtD
Paricalcitol—Dermatitis—Temozolomide—brain cancer	0.000541	0.00112	CcSEcCtD
Paricalcitol—Headache—Temozolomide—brain cancer	0.000538	0.00112	CcSEcCtD
Paricalcitol—Nausea—Carmustine—brain cancer	0.000528	0.0011	CcSEcCtD
Paricalcitol—Nausea—Temozolomide—brain cancer	0.00051	0.00106	CcSEcCtD
Paricalcitol—Hypersensitivity—Etoposide—brain cancer	0.000507	0.00105	CcSEcCtD
Paricalcitol—Asthenia—Etoposide—brain cancer	0.000493	0.00102	CcSEcCtD
Paricalcitol—Pruritus—Etoposide—brain cancer	0.000487	0.00101	CcSEcCtD
Paricalcitol—Diarrhoea—Etoposide—brain cancer	0.000471	0.000977	CcSEcCtD
Paricalcitol—VDR—Generic Transcription Pathway—ESR2—brain cancer	0.000468	0.00389	CbGpPWpGaD
Paricalcitol—Dizziness—Etoposide—brain cancer	0.000455	0.000944	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CYP2C9—brain cancer	0.000452	0.00376	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—NOTCH2—brain cancer	0.000443	0.00369	CbGpPWpGaD
Paricalcitol—Vomiting—Etoposide—brain cancer	0.000437	0.000908	CcSEcCtD
Paricalcitol—Rash—Etoposide—brain cancer	0.000434	0.000901	CcSEcCtD
Paricalcitol—Dermatitis—Etoposide—brain cancer	0.000433	0.0009	CcSEcCtD
Paricalcitol—Headache—Etoposide—brain cancer	0.000431	0.000895	CcSEcCtD
Paricalcitol—Nausea—Etoposide—brain cancer	0.000408	0.000848	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—BSG—brain cancer	0.000384	0.0032	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—EGFR—brain cancer	0.000372	0.0031	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP2C9—brain cancer	0.000361	0.00301	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000343	0.00285	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000338	0.00281	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—IDH1—brain cancer	0.00033	0.00275	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—TP53—brain cancer	0.000313	0.0026	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—BSG—brain cancer	0.000307	0.00256	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000269	0.00224	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—IDH1—brain cancer	0.000264	0.0022	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ENO2—brain cancer	0.000261	0.00217	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—DNMT1—brain cancer	0.000251	0.00209	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—ESR2—brain cancer	0.000225	0.00187	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NOTCH2—brain cancer	0.000213	0.00177	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ENO2—brain cancer	0.000209	0.00174	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—SIRT1—brain cancer	0.000181	0.00151	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—MYC—brain cancer	0.000147	0.00123	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PIK3CG—brain cancer	0.00012	0.000997	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PIK3CG—brain cancer	9.57e-05	0.000797	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—MYC—brain cancer	7.1e-05	0.000591	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP2C9—brain cancer	5.86e-05	0.000488	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—BSG—brain cancer	4.98e-05	0.000415	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—IDH1—brain cancer	4.29e-05	0.000357	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ENO2—brain cancer	3.39e-05	0.000282	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3CG—brain cancer	1.55e-05	0.000129	CbGpPWpGaD
